Delivery Order SPE2DB20D3303-SPE2DB25FA1SA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,064.70 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed price delivery order, awarded on June 17, 2025, with completion scheduled for June 18, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication. This non-set-aside, competitively awarded contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. The contract, designated as a firm fixed price delivery order without set-aside provisions, is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This non-competitive delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, operates under a firm fixed-price arrangement and represents a single-line pharmaceutical procurement to support federal medical supply needs. The award is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication, valued at $3,931.20. This non-set-aside contract was awarded competitively on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizing firm fixed pricing. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract utilizes no set-aside designation and was competitively awarded. Performance will...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by June 2, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award, issued on July 24, 2025, with completion targeted for July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1SADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication, under a firm fixed-price contract valued at $1,474.20. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical supply vehicle for military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies under its DLA contract, including brand-name and generic medications, vaccines, and specialized medical commodities. This particular delivery order exemplifies the routine execution of the larger IDC vehicle, fulfilling specific pharmaceutical requirements for federal military and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/23/25 |